Prevalence of Frailty and Associated Factors in Coronary Artery Bypass Patients
- Disease/Condition
- Frailty
- Drug/Device/Intervention
- prevalence of frailty
- Study type
- Observational
- Intervention type
- other
- Primary sponsor
- Uşak University
- Location
- Usak, Turkey
- Phase
- N/A
- Start date
- Feb 18, 2021
- End date
- Feb 18, 2022
- Enrollment
- 96 participants
Prevalence of frailty
This study aimed to determine the prevalence of and factors affecting frailty in patients
 with coronary artery bypass graft.
 
 The main question it aims to answer are:
 
 What are the prevalence of and factors affecting frailty in patients with coronary artery
 bypass graft Type of study: descriptive cross-sectional study Participant population:
 coronary artery bypass grafting patients
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06343168
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06343168 through Pure Global AI's free database. This phase not specified trial is sponsored by Uşak University and is currently Completed. The study focuses on Frailty. Target enrollment is 96 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.